Orange Book product · Generic (ANDA)
URSODIOL
URSODIOL
At a glance
Aug 14, 2024
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 14, 2024
1 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
URSODIOL
Strength
250MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 214717
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of URSODIOL
- 1997URSO 250Brand (NDA)
NDA 020675 · ABBVIE
- 1987ACTIGALLBrand (NDA)
NDA 019594 · TEVA BRANDED PHARM
- 2026URSODIOLGeneric (ANDA)
ANDA 210344 · STRIDES PHARMA
- 2022URSODIOLGeneric (ANDA)
ANDA 214849 · AUROBINDO PHARMA LTD
- 2021URSODIOLGeneric (ANDA)
ANDA 214329 · RK PHARMA
- 2020URSODIOLGeneric (ANDA)
ANDA 214295 · ZYDUS LIFESCIENCES
- 2020URSODIOLGeneric (ANDA)
ANDA 213504 · STRIDES PHARMA
- 2020URSODIOLGeneric (ANDA)
ANDA 213555 · CHARTWELL RX
- 2020URSODIOLGeneric (ANDA)
ANDA 205789 · LGM PHARMA
- 2020URSODIOLGeneric (ANDA)
ANDA 213200 · RISING
- 2019URSODIOLGeneric (ANDA)
ANDA 212452 · HIBROW HLTHCARE
- 2018URSODIOLGeneric (ANDA)
ANDA 211145 · ZYDUS LIFESCIENCES
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
